Dextrose 30%

Welcome to Dwaey, specifically on Dextrose 30% page.
This medicine contains important and useful components, as it consists of
Dextrose 30% is available in the market in concentration.

Generic Name of Dextrose 30% - Learn More

Dextrose 30%

Dextrose 30% Precaution - What You Need to Know

Dextrose 30% is a hypertonic glucose solution that requires careful consideration when used in patients with certain conditions. Patients with uncontrolled diabetes or hyperglycemia should not receive Dextrose 30% without proper monitoring, as it can cause rapid increases in blood glucose levels. This can lead to hyperglycemia, which may result in complications like diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS), especially in patients with type 1 or type 2 diabetes who do not have adequate insulin coverage. Blood glucose levels should be monitored frequently during and after administration.

Pregnant women should only receive Dextrose 30% when absolutely necessary, and it should be administered under close medical supervision, as glucose can cross the placenta. Elevated glucose levels may adversely affect both maternal and fetal health, so maternal and fetal blood glucose levels should be monitored closely. Similarly, breastfeeding mothers should be cautious when using Dextrose 30%, as excess glucose may be excreted in breast milk and affect the infant's glucose metabolism.

In patients with compromised renal function, such as those with kidney disease or reduced glomerular filtration rate (GFR), the use of Dextrose 30% may result in difficulty clearing excess glucose from the bloodstream, potentially leading to fluid overload, electrolyte imbalances, or worsening renal function. Heart failure patients are at particular risk of fluid overload, which could exacerbate symptoms such as edema or pulmonary congestion. Careful monitoring of fluid balance, renal function, and electrolytes is essential during therapy with Dextrose 30%.

Dextrose 30% Indication - Uses and Benefits

Dextrose 30% is primarily used for the rapid treatment of moderate to severe hypoglycemia, especially in patients who are unable to consume oral glucose due to altered consciousness, vomiting, or difficulty swallowing. It is commonly used in emergency medical situations such as severe insulin overdose, acute diabetic emergencies, or critical illness where hypoglycemia is a concern. Dextrose 30% provides a quick, concentrated source of glucose that can rapidly raise blood glucose levels and prevent potentially dangerous symptoms of hypoglycemia, such as seizures, loss of consciousness, or brain damage.

In addition to treating hypoglycemia, Dextrose 30% may be used in fluid resuscitation therapy for patients who are in shock, trauma, or undergoing major surgery. This solution can be used to restore circulating volume and provide an immediate source of energy to vital organs. Dextrose 30% is also used in parenteral nutrition in patients who cannot consume food orally, particularly in critically ill or malnourished patients who require glucose supplementation.

Off-label uses of Dextrose 30% may include its use for the treatment of severe dehydration or to provide a source of glucose for patients in intensive care, though its use in these contexts should be based on the patient’s condition and healthcare provider's discretion.

Dextrose 30% Contraindications - Important Warnings

Dextrose 30% is contraindicated in patients with severe hyperglycemia or uncontrolled diabetes. Its high glucose concentration can exacerbate hyperglycemia, leading to diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS), which can be life-threatening if not managed appropriately. It is also contraindicated in individuals who have known hypersensitivity to dextrose or any components of the solution.

Patients with renal failure or severe kidney impairment should avoid Dextrose 30%, as their kidneys may be unable to effectively clear excess glucose from the bloodstream, leading to fluid overload, hyperglycemia, and electrolyte imbalances. In patients with heart failure, fluid retention may exacerbate symptoms of edema, pulmonary congestion, and hypertension. Therefore, caution should be exercised when administering Dextrose 30% to patients with cardiovascular conditions that predispose them to fluid overload.

Neonates and infants should not receive Dextrose 30% due to their immature glucose metabolism and the risk of hyperglycemia, fluid imbalance, and other metabolic disturbances. Additionally, individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency should not receive this solution, as it may trigger hemolysis.

Dextrose 30% Side Effects - What to Expect

The most common side effects associated with Dextrose 30% include hyperglycemia and fluid overload. Hyperglycemia can result in symptoms such as excessive thirst, frequent urination, fatigue, and blurred vision. In severe cases, persistent hyperglycemia can lead to complications like diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS), which are potentially life-threatening and require immediate intervention.

Fluid overload is another major concern, particularly in patients with heart failure or kidney disease. Excessive infusion of Dextrose 30% can lead to edema (swelling), elevated blood pressure, and worsening heart failure symptoms, including shortness of breath and chest discomfort. Electrolyte imbalances, such as hypernatremia or hypokalemia, can occur due to shifts in body fluids during the infusion process.

Infusion-related side effects can also include pain, irritation, or thrombophlebitis (inflammation of the vein) at the injection site, especially when the solution is administered peripherally or rapidly. In some cases, patients may develop nausea, vomiting, or dizziness if the glucose infusion causes a rapid shift in fluid or glucose levels in the bloodstream.

Patients receiving Dextrose 30% should be monitored for any signs of adverse effects and adjustments should be made as necessary to minimize complications.

Dextrose 30% Pregnancy Category ID - Safety Information

3

Dextrose 30% Mode of Action - How It Works

Dextrose 30% exerts its therapeutic effects by providing a rapid and concentrated source of glucose, which is immediately available for cellular energy production. Once infused intravenously, glucose enters the bloodstream and is distributed to tissues throughout the body, particularly to high-energy-demand organs such as the brain and muscles. This leads to an immediate increase in blood glucose levels, which is crucial for preventing the severe consequences of hypoglycemia, including confusion, seizures, or loss of consciousness.

The osmotic properties of Dextrose 30% also help to restore circulatory volume in patients who are dehydrated or in shock. The hyperosmolar nature of the solution draws water into the bloodstream, increasing plasma volume and improving tissue perfusion. This makes it useful in fluid resuscitation, especially in critically ill patients.

At the cellular level, glucose is metabolized via glycolysis and oxidative phosphorylation to generate ATP, the primary energy currency for cellular processes. This ensures that energy-deprived cells, particularly those in the brain, receive the necessary fuel to function normally. Any excess glucose not immediately needed for energy is stored as glycogen in liver and muscle cells or is excreted by the kidneys if blood glucose levels remain elevated.

Dextrose 30% Drug Interactions - What to Avoid

Dextrose 30% interacts with several medications, particularly those that affect blood glucose regulation. Corticosteroids, thiazide diuretics, certain adrenergic agents (such as epinephrine), and other drugs that increase blood glucose levels can exacerbate the hyperglycemic effects of Dextrose 30%. This may require adjustments in insulin or oral hypoglycemic therapy to prevent severe hyperglycemia.

When used with insulin, Dextrose 30% may require careful monitoring and adjustment of insulin doses, as rapid glucose infusion can lead to fluctuations in blood glucose. Patients receiving oral hypoglycemic medications or insulin should be monitored closely for hyperglycemia, and insulin therapy may need to be adjusted accordingly.

The use of Dextrose 30% with other intravenous fluids or medications that affect fluid balance, such as potassium or calcium infusions, can lead to electrolyte imbalances. This may increase the risk of conditions such as hypokalemia or hyperkalemia. Electrolyte levels should be monitored closely, particularly if the solution is being administered alongside other fluids that alter the body's electrolyte balance.

Alcohol use should be avoided during treatment with Dextrose 30%, as alcohol can impair the body’s ability to regulate blood glucose, increasing the risk of both hypoglycemia and hyperglycemia, depending on the individual’s condition.

Dextrose 30% Adult Dose - Recommended Dosage

The standard adult dose of Dextrose 30% for hypoglycemia is generally 20-50 mL administered intravenously as a bolus, depending on the severity of the hypoglycemic episode. This can be repeated if blood glucose levels do not rise adequately or if symptoms of hypoglycemia persist. The initial bolus of 25-30 mL of Dextrose 30% provides a rapid and significant increase in blood glucose levels.

For patients requiring fluid resuscitation, the infusion rate of Dextrose 30% is typically 100-200 mL per hour, adjusted based on the patient's condition, response to treatment, and overall fluid needs. The maximum rate should not exceed 1 g/kg/min to avoid complications such as hyperglycemia and fluid overload.

The dose should be tailored to the patient’s clinical needs, and blood glucose levels should be monitored regularly to ensure that the desired therapeutic effect is achieved.

Dextrose 30% Child Dose - Dosage for Children

Dextrose 30% should be used cautiously in pediatric patients due to the high glucose concentration. The typical pediatric dose for treating hypoglycemia is calculated based on weight, with an initial dose of approximately 2-5 mL/kg administered intravenously. The exact dose should be adjusted depending on the child's blood glucose levels and clinical condition.

In neonates and infants, Dextrose 30% is generally avoided due to the risk of hyperglycemia and metabolic disturbances, as their glucose metabolism may not be fully developed. In these cases, more dilute solutions such as Dextrose 10% or 20% are typically preferred. Close monitoring of blood glucose levels and electrolytes is crucial during therapy, and adjustments should be made as necessary to prevent adverse effects.

Dextrose 30% Renal Dose - Dosage for Kidney Conditions

In patients with renal impairment, Dextrose 30% should be used with caution, as impaired renal function can lead to reduced clearance of glucose. The infusion rate and volume should be carefully adjusted to prevent fluid overload, especially in patients with severe kidney dysfunction. Serum glucose and renal function (e.g., serum creatinine, glomerular filtration rate) should be monitored closely during treatment.

For patients with end-stage renal disease or those undergoing dialysis, the use of Dextrose 30% is generally avoided due to the risk of fluid retention and the kidney's inability to clear excess glucose. In these patients, alternative, lower-concentration glucose solutions or other methods of glucose supplementation may be considered to prevent complications.